技术与痴呆症 会议前会议
1Unidad de Cerebro Saludable, Hospital Clinico Universidad de Chile, Santiago, Metropolitana, Chile.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 23, 2025
概括
NeoMayor移动健康应用程序有效地促进了老年人的健康衰老. 该工具在心血管健康,身体功能和饮食方面显著改善,为健康的生活方式提供了可访问的解决方案.
科学领域:
- 老年学与公共卫生
- 数字健康干预措施 数字健康干预措施
- 心血管健康和认知功能
背景情况:
- 拉丁美洲面临着人口老龄化,增加了与年龄相关的疾病负担,如心血管疾病和痴呆症.
- 移动健康 (mHealth) 应用程序为促进老年人健康生活方式提供了一个有希望的途径.
- 智利缺乏用于多式联络生活方式干预的mHealth工具,尽管有证据表明它们的有效性.
研究的目的:
- 描述NeoMayor mHealth应用程序的开发和验证过程.
- 评估通过mHealth提供的多式联络生活方式干预措施对老年人健康的影响.
主要方法:
- 这款NeoMayor应用程序是通过26次与用户的共同创作会议,专家咨询和文献评论来开发的.
- 一项试点研究涉及60名独立和认知正常的老年人.
- 在使用NeoMayor应用程序进行为期两个月的干预期之前和之后进行了临床和认知评估.
主要成果:
- 参与者表现出心血管健康的显著改善,生命必需8指数从64增加到68 (p <0.001).
- 关键健康指标有所改善,包括降低缩血压 (10 mmHg),腰围 (6 cm),体重和禁食葡萄糖水平.
- 在体力活动 (IPAQ分数),体力表现 (SPPB),移动性 (定时和去测试) 和饮食习惯 (MeDDiet分数) 中观察到显著的改善.
结论:
- NeoMayor是智利首个mHealth工具,旨在促进老年人的健康生活方式,心血管和大脑健康.
- 在试点研究中,该应用程序在多个健康领域产生了显著的积极影响.
- 在老年人群中,NeoMayor为促进健康老龄化提供了一种有效,易于获得和负担得起的解决方案.
相关概念视频
Dementia
482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
482
Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K


